Richard Edmund Phillips, MD, PhD

Medical Oncology, Neurology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Headshot of Richard Edmund Phillips, MD, PhD
Penn Medicine Provider

About me

  • Division Chief, Neuro-Oncology, Neurology
  • Program Director, Neuro-Oncology Fellowship
  • Presidential Assistant Professor of Neurology
  • Assistant Professor of Neurology in Genetics

I am a neuro-oncologist who specializes in caring for people with primary brain tumors as well as neurologic complications of cancer (e.g. brain and leptomeningeal metastases, paraneoplasia, radiation necrosis). I am humbled by the opportunity to work with patients and their families during what can be a very vulnerable time. I have a special interest in the biology of brain tumors and direct a research lab where we discover new insights into these tumors such that more effective therapies can be developed.

My education and training

  • Medical School: University of London
  • Residency: Massachusetts General Hospital
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Phillips is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Lagan E, Gannon D, Silva AJ, Bibawi P, Doherty AM, Nimmo D, McCole R, Monger C, Genesi GL, Vanderlinden A, Innes JA, Jones CLE, Yang L, Chen B, van Mierlo G, Jansen PWTC, Pednekar C, Von Kriegsheim A, Wynne K, Sánchez-Rivera FJ, Soto-Feliciano YM, Carcaboso AM, Vermeulen M, Oliviero G, Chen CW, Phillips RE, Bracken AP, Brien GL A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma , Molecular Cell , 85(11): 2025,2110-2127


Till JE, Seewald NJ, Yazdani Z, Wang Z, Ballinger D, Samberg H, Dandu S, Macia C, Yin M, Abdalla A, Prior T, Shah SS, Patel T, McCoy E, Mansour M, Wills CA, Bochenek V, Serrano J, Snuderl M, Phillips RE, O'Rourke DM, Amankulor NM, Nabavizadeh A, Desai AS, Gollomp K, Binder ZA, Zhou W, Bagley SJ, Carpenter EL. Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma , Clin Cancer Res, 31: 2025,1292-1304


Dáire Gannon, Eimear Lagan, Ademar Jesus Silva, Peter Bibawi, Anthony M. Doherty, Darragh Nimmo, Rachel McCole, Craig Monger, Giovani Genesi, Aurelie Vanderlinden Dibekeme, James A. Innes, Lu Yang, Bryan Chen, Guido van Mierlo, Pascal W.T.C Jansen, Keiran Wynne, Fran-cisco J. Sánchez-Rivera, Yadira M. Soto-Feliciano, Michiel Vermeulen, Giorgio Oliverio, Chun-Wei Chen, Richard E. Phillips, Adrian P. Bracken, Gerard L. Brien Specific cPRC1 complexes are co-opted to mediate oncogenic gene repression in diffuse midline glioma , Biorxiv: 2023


Liang R., Tomita D. Sasaki Y., Ginn J, Michino M., Huggins D., Baxt L., Kargman S., Shahid M., Kazuyoshi A., Duggan M., Stamford A., DeStanchina E., Liverton N., Meinke P., Foley M., Phillips R.E. A chemical strategy toward brain penetrant EZH2 inhibitors , ACS Medicinal Chemistry Letters, 13(3): 2022,377–387


Phillips RE, Soshnev AA, Allis CD. Epigenomic Reprogramming as a Driver of Malignant Glioma. , Cancer Cell, 38(5): 2020,647-660


Phillips RE, Soshnev AA, Allis CD. Epigenomic Reprogramming as a Driver of Malignant Glioma , Cancer Cell, 38: 2020,647-660


Phillips, R. E., Yang, Y., Smith, R. C., Thompson, B. M., Yamasaki, T., SotoFeliciano, Y. M., Funato, K., Liang, Y., Garcia-Bermudez, J., Wang, X., Garcia, B. A., Yamasaki, K., McDonald, J. G., Birsoy, K., Tabar, V., & Allis, C. D. Target identification reveals lanosterol synthase as a vulnerability in glioma , Proceedings of the National Academy of Sciences of the United States of America, 116(16): 2019,7957–7962


Phillips, R. E., Curran, K. J., & Khakoo, Y Management of late extraneural recurrence of medulloblastoma without high-dose chemotherapy. , Journal of Neuro-Oncology, 124(3): 2015,523–524


Awosika, O. O., Lyons, J. L., Ciarlini, P., Phillips, R. E., Alfson, E. D., Johnson, E. L., Koo, S., Marty, F., Drew, C., Zaki, S., Folkerth, R. D., & Klein, J. P. Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient. , Neurology , 80(18): 2013,1715–1717


Bartel, G., Brown, K., Phillips, R., Peng, Q., Zhou, W., Sacks, S. H., & Wong, W. Donor specific transplant tolerance is dependent on complement receptors , Transplant International , 26(1): 2013,99-108